As of 2024-12-15, the Intrinsic Value of Stayble Therapeutics AB (STABL.ST) is
-2.33 SEK. This STABL.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.47 SEK, the upside of Stayble Therapeutics AB is
-596.38%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.33 SEK
Intrinsic Value
STABL.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.33 - -2.33 |
-2.33 |
-596.38% |
| P/E |
(6.17) - (9.14) |
(6.09) |
-1395.5% |
| DDM - Stable |
(7.63) - (235.39) |
(121.51) |
-25953.3% |
| DDM - Multi |
(4.46) - (107.19) |
(8.57) |
-1922.7% |
STABL.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
20.55 |
| Beta |
0.45 |
| Outstanding shares (mil) |
43.72 |
| Enterprise Value (mil) |
13.34 |
| Market risk premium |
5.10% |
| Cost of Equity |
6.23% |
| Cost of Debt |
5.00% |
| WACC |
6.14% |